Unveiling Novel Payload & ADC Design Attributes & Performance for Next Generation ADC Targeting & Tolerability
- Highlighting the drivers for ADC development beyond traditional cytotoxic payloads
- Detailing development and design of more well-tolerated ADCs with improved therapeutic index and defined patient populations
- Showcasing late-stage preclinical development of novel ADC programs preparing for IND applications